Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet
Similar Posts
FDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes
The U.S. Food and Drug Administration (FDA) is warning that cases of a rare but serious infection of the genitals and area around the genitals have been reported with the class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors.Hubei JXBio Pharmaceutical Co., Ltd. – 3/14/2025
Hubei JXBio Pharmaceutical Co., Ltd. – 3/14/2025. Country: China. Record Type: 483FDA Grand Rounds – Anti-biofilm Technologies for Enhancing the Safety of Medical Device Surfaces – 05/29/2025
Anti-biofilm Technologies for Enhancing the Safety of Medical Device Surfaces, May 29, 2025.FDA Listing of Authorized Generics
FDA Listing of Authorized GenericsExpanded Access to Investigational Drugs for Treatment Use – Questions and Answers – 04/15/2026
An informative webinar on the FDA guidance Expanded Access to Investigational Drugs for Treatment Use: Questions and AnswersSiluetaYa Recalls Tejocote Product Because of Possible Health Risk
SiluetaYa is recalling its tejocote root because FDA analysis has determined that the products appear to be Thevetia peruviana, or yellow oleander. All parts of the yellow oleander plant are known to contain cardiac glycosides, which are highly toxic to humans and animals. Ingestion of yellow oleand